Health policy and healthcare delivery are primarily a Member State competence. However, health initiatives are often coordinated at the EU level in areas necessitating cross-border action, such as rare and complex diseases. In addition, the European Health Union has been an increasingly prominent policy orientation, fostering Member State cooperation since the COVID-19 pandemic. As rare and complex conditions with a significant societal burden, childhood cancers and cancer sequelae affecting survivors necessitate targeted approaches supported by both national and EU stakeholders.

The PanCareFollowUp consortium has developed overarching policy proposals to set the scene and provide orientations for a favourable policy environment for Survivorship Care, as well as by producing five key recommendations related to the replication of the Care intervention across Europe, shown below. While these recommendations address the European policy landscape, they can serve as a foundation for policy recommendations in other areas.


PanCare strives to provide accurate and complete information that is up-to-date as of the date of publication.

No warranty or representation, expressed or implied, is made concerning the accuracy, reliability, completeness, relevance, or timeliness of this information.

The PanCare materials are free to use for anyone aiming to inform about late effects and long-term survivorship care. However, no financial advantage may be achieved. All communication should reference PanCare and link to the PanCare website.